olaparib,177lu-psma-617
astrazeneca,merck,novartis
['olaparib', 'luparp', 'crpc']
luparp (lupsma + olaparib for psma+ mcrpc pts) ctc analysis: detectable ctcs: 23/26--&gt; w/ tx detectable psma+ ctcs: 17/23 at progression: 100% w/ detectable ctcs (56% psma+) 9/15 pts with 50% ctc count from baseline to w12 had a psa50 response #asco23 
MD, MSc | @UofTUrology @SUO_YUO Fellow & @IHPMEUofT CEHCR PhD| Previously: @MCG_Urology and @AUB_Lebanon 🇱🇧